Crime scene photoCAPITOL WEEKLY PODCAST: In the wake of the horrific January 21 shooting that killed 11 people in Monterey Park, Gov. Newsom visited hospitalized survivors. His conversation with one patient revealed an added stress for survivors of gun violence and other violent crime: the inability to cover expenses incurred or wages lost due to the incident.
A laboratory pipette with fluid and test tubes for cancer research. (Photo: CI Photos, via Shutterstock)Call it “The Case of the Killer Cells.” It is an $8 million matter involving an effort by California’s ambitious stem cell agency to develop cures for particularly tenacious and fatal cancers. The cash is snarled in an “embarrassing” conflict of interest, however, not to mention an irregular vote on the application for research funding from the stem cell agency.
Mesenchymal stem cells are injected into the knee of a patient. (Photo: Wikimedia Commons photo, via VT Digger)They could be called the “UC Caucus,” although that may presume too much. Nonetheless, they come from an institution that has pulled down $1.2 billion from the California state stem cell agency, more than any other enterprise during the last 16 years.
A pipette and receptacles used in stem cell research. (Photo: CI Photos)The talk at the California stem cell agency this week was of ”boiling the ocean,” the meaning of “unlikely” and “DEI.” All of which involves how $5.5 billion in taxpayer dollars will be used over the next decade or so.
Stem cell research using what's known as a PCR strip. (Image: Science Photo via Shutterstock) California’s ambitious stem cell agency has launched itself on a new, $5.5 billion journey, approving a plan to hand out $182 million to researchers by the middle of next year and beefing up its efforts to bring equality to therapies and scientific labs.
A scientist at work in a biological lab. (Photo: anyaivanova)California voters have apparently approved spending $5.5 billion more on stem cell research over the next 10 to 15 years and significantly broadening the scope of its state stem cell agency, according to unofficial figures this morning.
Illustration of California by ymgerman, via Shutterstock)OPINION: Ten years ago, I sat in my office cubicle. I squinted to make out the grainy online image of Elaine Howle, the California State Auditor, pulling out a series of bingo balls. My desktop speaker crackled, and it was hard to read the numbers on the balls. I kept the volume low so my coworkers couldn’t eavesdrop.
The Owens River cuts through the Owens Valley near the east slope of the Sierra. (Photo: Bart Everett)California voters may be asked this year to approve $13 billion in two separate water bonds that promise to pay for safe drinking water and improve flood protection. Proposition 68 is a $4.1 billion measure and is already set for the June 5 ballot. The Water Supply and Water Quality Act is an $8.9 billion bond and could come up for a vote in November. The Secretary of State’s office is reviewing the signatures turned in and should decide by the end of the month whether it qualifies for the ballot.
The CalPERS headquarters in Sacramento. (Photo Shutterstock)A bill by state Sen. Steven Glazer, D-Orinda, giving new state workers the option new University of California workers received two years ago, a 401(k)-style plan rather than a pension, is opposed by unions and soon may be opposed by CalPERS. More than a third of eligible new UC employees have chosen a 401(k)-style plan. Instead of a guaranteed lifetime monthly pension check, the 401(k) plan that replaced pensions in most of the private sector uses individual tax-deferred investments to build a retirement fund.
A stem cell researcher at work. (Photo: 18percentgrey, via Shutterstock)The California stem cell agency has awarded $33 million for clinical trial research, but not before some governing board members questioned the appropriateness of backing an effort to treat osteoarthritis of the knee. The awards on Thursday bring to 43 the number of clinical trials funded by the stem cell agency, formally known as the California Institute for Regenerative Medicine (CIRM).